Mylan
1000 Mylan Boulevard
Canonsburg
Pennsylvania
15317
United States
Tel: 724-514-1800
Website: http://www.mylan.com/
About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, Mylan innovates to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership
YEAR FOUNDED:
1961
LEADERSHIP:
Founders: Milan Puskar, and Don Panoz
CEO: Heather Bresch
CFO: Neil Dimick
PRODUCTS:
All Products
991 articles about Mylan
-
Mylan Inc.'s Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
8/18/2009
-
US FDA Clears Key Mylan Inc. Plant, Closes Probe
8/14/2009
-
Mylan Inc. Receives FDA Approval for Generic Version of Migraine Treatment Imitrex(R)
8/11/2009
-
President Clinton, Pfizer Inc., and Mylan Inc. Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries
8/6/2009
-
FDA Expects to Wrap up Mylan Inc. Probe Within Weeks
8/4/2009
-
Mylan Inc. Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
7/30/2009
-
Mylan Inc. Reshuffles Management; Heather Bresch Promoted To President, Rajiv Malik Appointed COO
7/29/2009
-
Mylan Inc. Reports That the FDA Determined That All Accusations Were Unfounded
7/28/2009
-
Mylan Inc. Reiterates and Stands Behind Its 48-Year Commitment and Track Record of Quality
7/27/2009
-
Mylan Inc. Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
7/20/2009
-
Mylan Inc. Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R) Begins Shipment of Products
7/16/2009
-
Mylan Inc. Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
7/7/2009
-
Mylan Inc. Schedules Second Quarter 2009 Financial Results Conference Call and Live Webcast
7/6/2009
-
Mylan Inc. Announces Strategic Collaboration with BioCon Limited to Enter the Global Generic Biologics Market
6/29/2009
-
Mylan Inc. Receives FDA Approval for Additional Strength of Generic Restoril(R)
6/18/2009
-
Mylan Inc. Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
6/3/2009
-
Mylan Inc.'s Chief Operating Officer to Testify Before Congress Concerning Patent Settlements
6/2/2009
-
Mylan Inc. Announces Successful Matrix Delisting Offer
6/1/2009
-
Mylan Inc. Receives Tentative FDA Approval for Generic Version of Singulair(R)
5/29/2009
-
Mylan Inc. Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept(R)
5/7/2009